![Novel oral anticoagulants and reversal agents: Considerations for clinical development]()
Novel oral anticoagulants and reversal agents: Considerations for clinical developmentSarich, Troy C.; Seltzer, Jonathan H.; Berkowitz, Scott D.; Costin', James; Curnutte, John T.; Gibson, C. Michael; Hoffman, Maureane; Kaminskas, Edvardas; Krucoff, Mitchell W.; Levy, Jerrold H.; Mintz, Paul D.; Reilly, Paul A.; Sager, Philip T.; Singer, Daniel E.; Stockbridge, Norman; Weitz, Jeffrey I.; Kowey, Peter R. · American Heart Journal · 2015